Ellume at Home Covid Test Recall – Class Action Investigation

Ellume at Home Covid Test Recall – Class Action Investigation

Chimicles Schwartz Kriner & Donaldson-Smith (CSK&D) is investigating a potential class action lawsuit related to a recall of 2.2 million at-home coronavirus (COVID-19) tests made by digital diagnostics firm Ellume due to false positive results. The FDA has issued a Class 1 recall related to these tests, which is the most serious level of recall. Ellume’s at-home test claims to detect proteins from the SARS-CoV-2 virus through a less invasive nasal swab than other tests. But according to the FDA, false positives may occur because of a manufacturing issue. It is estimated that 660,000 of the effected tests have already been taken by consumers.

If you bought one of these tests, whether or not you have taken the test, we would like to hear from you.

(*) Indicates required field: When communicating with us through this site or otherwise in connection with a matter for which we do not already represent you, your communication may not be treated as privileged or confidential, and does not create an attorney-client relationship between you and our Firm.

Attorneys for this case:

Benjamin F. Johns
Alex M. Kashsurba